Compare · head to head
Ambarella vs Medpaces
Medpaces ranks higher overall — 360 rank 96 vs 19.
Medpaces leads on Value (54 vs 38), Quality (83 vs 33), Growth (64 vs 48) and Safety (63 vs 44). Ambarella leads on Sentiment (52 vs 43).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Chips & Hardware | Health Care |
| Industry | Semiconductors & Semiconductor Equipment | Life Sciences Tools & Services |
| Size | Medium | Large |
| ISIN | KYG037AX1015 | US58506Q1094 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 19 | 96 |
| Value | 38 | 54 |
| Quality | 33 | 83 |
| Growth | 48 | 64 |
| Safety | 44 | 63 |
| Sentiment | 52 | 43 |
| Quality details | ||
| Profitability | 25 | 95 |
| Cash Truth | 41 | 71 |
Ambarella vs Quest DiagnosticsAmbarella vs PersonalisAmbarella vs Tango TherapeuticsAmbarella vs Pacific Biosciences of CaliforniaAdd a third stock →
Full analyses: Ambarella · Medpaces
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100